"Placebo Effect" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An effect usually, but not necessarily, beneficial that is attributable to an expectation that the regimen will have an effect, i.e., the effect is due to the power of suggestion.
| Descriptor ID |
D015990
|
| MeSH Number(s) |
N05.715.350.350.625 N06.850.490.734.875
|
| Concept/Terms |
Placebo Effect- Placebo Effect
- Effect, Placebo
- Effects, Placebo
- Placebo Effects
|
Below are MeSH descriptors whose meaning is more general than "Placebo Effect".
Below are MeSH descriptors whose meaning is more specific than "Placebo Effect".
This graph shows the total number of publications written about "Placebo Effect" by people in this website by year, and whether "Placebo Effect" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 2003 | 2 | 0 | 2 |
| 2008 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2017 | 4 | 4 | 8 |
| 2018 | 7 | 13 | 20 |
| 2019 | 0 | 2 | 2 |
| 2020 | 1 | 1 | 2 |
| 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Placebo Effect" by people in Profiles.
-
Resveratrol supplementation reduces ACE2 expression in human adipose tissue. Adipocyte. 2021 12; 10(1):408-411.
-
Genetics of symptom remission in outpatients with COVID-19. Sci Rep. 2021 05 25; 11(1):10847.
-
Placebo use and unblinding in COVID-19 vaccine trials: recommendations of a WHO Expert Working Group. Nat Med. 2021 04; 27(4):569-570.
-
Providing open-label placebos remotely-A randomized controlled trial in allergic rhinitis. PLoS One. 2021; 16(3):e0248367.
-
Editorial: Demystifying the Placebo Effect. Am J Epidemiol. 2021 01 04; 190(1):2-9.
-
Rethinking Clinical Trials and Personalized Medicine with Placebogenomics and Placebo Dose. OMICS. 2021 01; 25(1):1-12.
-
Secukinumab lowers expression of ACE2 in affected skin of patients with psoriasis. J Allergy Clin Immunol. 2021 03; 147(3):1107-1109.e2.
-
The Essential Medicinal Chemistry of Cannabidiol (CBD). J Med Chem. 2020 11 12; 63(21):12137-12155.
-
Alirocumab efficacy and safety by race and ethnicity: Analysis from 3 ODYSSEY phase 3 trials. J Clin Lipidol. 2019 Jul - Aug; 13(4):586-593.e5.
-
Epidemiology and burden of influenza in healthy children aged 6 to 35 months: analysis of data from the placebo arm of a phase III efficacy trial. BMC Infect Dis. 2019 Apr 04; 19(1):308.